“…Our MMAD in combination with our previously presented chronic interfaces (Yazdan-Shahmorad et al ., 2015, 2016; Griggs et al ., 2019) equip us for a variety of research pursuits. Moving forward, we plan to capitalize on our previous optogenetic (Ledochowitsch et al ., 2015; Yazdan-Shahmorad et al ., 2015, 2016, 2018b, 2018a, 2018c; Khateeb et al ., 2019a; Ojemann et al ., 2020; Tremblay et al ., 2020) and imaging (Khateeb et al ., 2019b; Macknik et al ., 2019) experience as we pioneer the experimental spaces unveiled by the merging of large-scale ECoG and large-scale optical access to the NHP cortex. The synergistic power of these technologies poise us to build on our past work investigating neural plasticity (Yazdan-Shahmorad et al ., 2018a; Bloch et al ., 2019) as we study large-scale, chronic neural phenomena including neural disease, damage, and recovery.…”